Georgette Asherman, founder of Direct Effects, has been a professional statistician in pharmaceuticals, consumer products, business services and public policy for over 10 years. She has been associated with organizations such as Unilever, Bristol-Myers Squibb, Chase Manhattan Credit Card Services, and the New Jersey Department of Health. In recent years she has developed an interest in quantitative aspects of modern biological sciences. She has worked in clinical and non-clinical biostatistics, chemistry data analysis and instrument capability studies. Previous business experience includes direct mail and credit risk modeling, satisfaction and preference studies, and other market research activities. On the policy side she has been involved in public health survey analysis, data management, and sampling design for audits of compliance. She holds an M.S. in Statistics from Rutgers University and a B.A. from Cornell University. She is a member of the American Statistical Association and the New York Area SAS Users Group.

Affiliates bring expertise in database design and implementation to assure that techniques are cohesive with current computing practices. Programming for front-end development is provided as desired.